Puma Biotechnology Inc (PBYI.OQ)
15 Dec 2017
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|47||2011||Chairman of the Board, President, Chief Executive Officer|
|69||2011||Senior Vice President - Finance and Administration, Treasurer|
|59||2017||Chief Scientific Officer, Chief Medical Officer|
|50||2015||Chief Commercial Officer|
- BRIEF-Daiichi Sankyo And Puma Biotechnology To Collaborate With Major Cancer Center In HER2-Mutated Cancer
- BRIEF-Puma Biotechnology Announces Positive Outcome Of European Opposition Proceedings
- BRIEF-PUMA BIOTECHNOLOGY, SPECIALISED THERAPEUTICS ASIA AGREE TO COMMERCIALIZE NERLYNX IN SOUTH EAST ASIA
- BRIEF-Puma Biotechnology reports Q3 adj. loss per share $1.36
- BRIEF-Puma Biotechnology secures $100 mln term loan from Silicon Valley Bank and Oxford Finance